Business Wire

Gigabit Britain Moves Closer to a Reality as Call Flow Deploys ADTRAN-Powered 10Gbps FTTH Infrastructure

Del

ADTRAN®, Inc., (NASDAQ: ADTN), a leading provider of next-generation open networking solutions, today announced that Call Flow has chosen its XGS-PON solution to power the UK’s first generation of symmetric multi-Gigabit Fibre-to-the-Home (FTTH) services. The rapidly-growing ultrafast broadband operator has already built out up to 100Mbps FTTC-based services across Southern England and, to allow services to scale, has now selected ADTRAN’s next generation 10Gbps FTTH solution. This new architecture, fully compatible with Call Flow’s existing FTTH network, is set to bring about a step-change in symmetric multi-Gigabit access performance to differentiate it from other providers as it targets strategic expansion over the next 5–10 years.

With new rapidly emerging application demands such as AR/VR, 4K media streaming and the cloudification of software applications, all driving increased demands for lower latency and higher data rates, service providers are urgently re-evaluating further investments in GPON as their standard of choice for new rollouts. ADTRAN is a pioneer in 10G PON solutions, providing the contributions that triggered the introduction of XGS-PON into the ITU standards. As the editor for this effort, ADTRAN drove industry consensus which resulted in the approval and adoption of the XGS-PON ITU standard.

By supporting 10Gbps symmetric fixed wavelength PON over new or existing fibre optic infrastructures, XGS-PON provides the optimal blend between performance and price, permitting Call Flow to address both residential and business subscribers simultaneously on a single, common optical distribution network. Essentially doubling the useable life span of the optical distribution network, ADTRAN’s XGS-PON solutions protects operators’ network investments, providing the available capacity to support premium revenues for years to come.

“Call Flow has a leading vision for multi-Gigabit broadband services to better enable their communities for the global marketplace and to improve individual customers’ lives. Its strategic choice of XGS-PON is foundational to its ambition to be a prominent FTTH player in the UK market,” said Ronan Kelly, CTO for EMEA & APAC at ADTRAN. “This deployment adds to the global momentum building around 10 Gigabit PON as the primary access technology of choice for operators in developed broadband markets. Rapidly and cost-effectively satisfying subscriber demand and government targets, XGS-PON is the breakthrough the FTTH industry has been waiting for.”

“ADTRAN’s global leadership in Gigabit broadband solutions made it the ideal choice to address the rising bandwidth demands we anticipate for the next 5–10 years and beyond,” said Andy Conibere, CEO at Call Flow. “Its commitment to modern software-based, open architectures reinforced our view that it was the right partner for us. As Call Flow expands to answer more of the pent-up demand for Gigabit broadband services throughout the UK, XGS-PON will be essential to future-proofing our competitive advantage and delivering maximum value to our residential and business customers, as well as our investors.”

About ADTRAN

ADTRAN, Inc. is a leading global provider of networking and communications equipment. ADTRAN’s products enable voice, data, video and Internet communications across a variety of network infrastructures. ADTRAN solutions are currently in use by service providers, private enterprises, government organizations, and millions of individual users worldwide. For more information, please visit www.adtran.com.

About CallFlow

Call Flow is an innovative alternative network (alt-net) provider and has built both superfast and ultrafast networks across Kent, East Sussex, Hampshire and Berkshire. Call Flow is an industry leader in the use of Openreach’s ducts and poles (PIA/DPA) and Sub Loop Unbundling (SLU/FTTC). With several years experience of building innovative networks for various public bodies and BDUK, Call Flow is ideally placed to bring its skills to the fore in building 10 Gigabit PON networks in line with Government policy and Ofcom’s objective of infrastructure competition.

Contact information

Cohesive for ADTRAN
Kate Anderson, +44 (0) 1291 626200
adtran@wearecohesive.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 11:00Pressemelding

Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines

Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 08:10Pressemelding

Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest

Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 15:13Pressemelding

Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,

Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 14:00Pressemelding

Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With

Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 13:41Pressemelding

Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel

Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 12:00Pressemelding

Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i